Dyne Therapeutics, Inc. (DYN): Shares Outstanding
164.95M
As of 2025-12-31
165.67M
As of 2026-06-30
+43.7%
3-year compound annual growth
+29.6%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 164.95M | +61.2% | 2026-03-02, Balance as of period end |
| 2024-12-31 | 102.32M | +66.5% | 2026-03-02, Balance as of period end |
| 2023-12-31 | 61.47M | +10.5% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 55.64M | +7.9% | 2024-03-05, Balance as of period end |
| 2021-12-31 | 51.57M | +14.4% | 2023-03-02, Balance as of period end |
| 2020-12-31 | 45.08M | n/m | 2022-03-10, Balance as of period end |
| 2019-12-31 | 2.59M | n/a | 2021-03-04, Balance as of period end |